» Articles » PMID: 38667563

Effects of Erythropoietin-Promoted Fracture Healing on Bone Turnover Markers in Cats

Overview
Date 2024 Apr 26
PMID 38667563
Authors
Affiliations
Soon will be listed here.
Abstract

In orthopaedics, erythropoietin (EPO) is applied in the preoperative management of anaemic patients, but also as a stimulating factor to assist bone regeneration due to its angiogenic and osteoinductive potential. Since orthopaedists mainly rely on their clinical experience to assess bone healing, additional and more objective methods such as studying the dynamics of bone markers are needed. Therefore, the aim of this study was to investigate the plasma activity of bone-specific alkaline phosphatase (BALP), the N-terminal propeptide of type I collagen (PINP), the C-terminal telopeptide of type I collagen (CTX), and deoxypyridinoline (DPD) during the first 2 months of healing of comminuted fractures in cats, either non-stimulated or locally stimulated with recombinant human erythropoietin (rhEPO). The study included twelve cats of mixed breeds, aged 7.2 ± 4 months, weighing 2.11 ± 1.1 kg, with comminuted diaphyseal fractures of the femur. Surgical treatment with plate osteosynthesis was performed in all animals. The cats were randomly divided into two groups-a control ( = 6) and an EPO group ( = 6). The locally applied EPO leads to the increased activity of bone formation markers (BALP and PINP) during the second week after the osteosynthesis, preceding the peaks in the control group by two weeks. The studied bone resorption markers (DPD, CTX) varied insignificantly during the studied period. In conclusion, erythropoietin could serve as a promoter of bone healing in comminuted fractures in cats.

References
1.
Knych H, Finno C, Katzman S, Ryan D, McKemie D, Kass P . Clodronate detection and effects on markers of bone resorption are prolonged following a single administration to horses. Equine Vet J. 2022; 55(4):696-706. DOI: 10.1111/evj.13866. View

2.
Coulibaly M, Sietsema D, Burgers T, Mason J, Williams B, Jones C . Recent advances in the use of serological bone formation markers to monitor callus development and fracture healing. Crit Rev Eukaryot Gene Expr. 2010; 20(2):105-27. PMC: 3070362. DOI: 10.1615/critreveukargeneexpr.v20.i2.20. View

3.
Holstein J, Menger M, Scheuer C, Meier C, Culemann U, Wirbel R . Erythropoietin (EPO): EPO-receptor signaling improves early endochondral ossification and mechanical strength in fracture healing. Life Sci. 2006; 80(10):893-900. DOI: 10.1016/j.lfs.2006.11.023. View

4.
Matthaei M, Kononov S, Rehage J, Szura G, Leiter I, Hansen K . Does bone mobilization interfere with energy metabolism in transition cows?. JDS Commun. 2022; 3(6):451-455. PMC: 9709610. DOI: 10.3168/jdsc.2022-0239. View

5.
Hitz M, Jensen J, Eskildsen P . Bone mineral density and bone markers in patients with a recent low-energy fracture: effect of 1 y of treatment with calcium and vitamin D. Am J Clin Nutr. 2007; 86(1):251-9. DOI: 10.1093/ajcn/86.1.251. View